iShares MSCI Australia ETF vs Medpace Holdings Inc — how do they compare? iShares MSCI Australia ETF trades at $30.23, while Medpace Holdings Inc trades at $607 (market cap $16.90B). Which is the better fit depends on your goals.
| EWA | MEDP | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $30.41 | $620.59 |
52-Week Low | $24.95 | $393.42 |
Market Cap | — | $16.90B |
Enterprise Value | — | $16.52B |
Trailing returns across standard periods
Latest headlines on both assets
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →